LiveCareer-Resume

physician psychiatrist resume example with 20+ years of experience

Jessica
Claire
resumesample@example.com
(555) 432-1000,
, , 100 Montgomery St. 10th Floor
:
Summary

Highly qualified physician-researcher with extensive experience in clinical trials conduct and management. A psychiatrist, possessing strong listening skills including, when needed, deft work with inexperienced and even difficult individuals. Excellent communicator with strengths in oral and written formats. Accomplished in functioning in teams. Strong commitment to assuring high quality documentation and protocol adherence.

Skills
  • Strong ability to work effectively and respectfully with others
  • Strong medical knowledge
  • Extensive experience in clinical trials procedures and documentation
  • Strong writing and communication skills
Education and Training
University of Wisconsin Medical School Madison, WI, Expected in 05/1985 M.D. : With Honors - GPA :
  • Honors graduate
  • Elected to Alpha Omega Alpha as a 3rd year medical student (top 3% of class)
Massachusetts Institute of Technology Cambridge, MA Expected in 1980 ABD For PhD : Cellular And Molecular Biology - GPA :
University of Wisconsin - Madison Madison, WI Expected in 05/1977 Bachelor of Science : Zoology - GPA :
  • Honors graduate
Experience
Good Shepherd Hospice - Physician-psychiatrist
Floresville, TX, 09/2019 - 02/2021
  • Designed individualized care plans and conducted lab or diagnostic tests on patients to provide further information regarding particular mental disorders and general physical conditions.
  • Collaborated with nurses, doctors, social workers and psychologist to discuss treatment plans and progress.
Boys Town - Chief Medical Officer
Spirit Lake, IA, 11/2017 - 01/2019
  • Planned and developed new clinical programs and initiatives and managed and maintained performance improvement processes as defined in business plans.
  • Maintained good communication between department heads, medical staff and governing boards by attending board meetings and synchronizing interdepartmental functioning.
  • Oversaw day-to-day practice functions, patient care, medical and administrative staff and business activities.
  • Developed and actualized strategies to maintain highest standards of care.
  • Supervised clinical staff, providing continuous professional development opportunities and training to maintain and strengthen competencies.
  • Implemented procedures to achieve and maintain hospital accreditation by both the Wisconsin Department of Health Service and The Joint Commission.
  • Devised, implemented and evaluated medical practice delivery models to achieve patient care and outcome goals.
Sound Inpatient Physicians - Chief, Hospitalist Psychiatry Section
Spokane, WA, 08/2014 - 01/2019
  • Spearheaded treatment protocol creation, rollout and training for recruitment and onboarding training of junior psychiatrists.
  • Developed and maintained daytime, weeknight and weekend call schedule for large psychiatric hospitalist group.
  • Monitored, quantified, and improved psychiatric care quality, documentation and patient satisfaction.
  • Mentored professional development of generalist and specialist psychiatric hospitalists.
  • Enhanced physician staffing and clinical quality for addiction, partial hospital, and inpatient hospital programs.
  • Increased employed psychiatrists by 150%
  • Decreased psychiatric staff turnover by 60%
Boys Town - Medical Director, Intensive Psychiatric Treatment
Omaha, NE, 08/2014 - 01/2019
  • Maintained good communication between department heads, medical staff and Hospital administration by attending weekly meetings and synchronizing interdepartmental functioning.
  • Planned and developed new clinical programs and initiatives and managed and maintained performance improvement processes as defined in business plans.
  • Oversaw physician qualification process, staff and patient safety procedures, and quality improvement projects including data analysis.
  • Established monthly difficult case conference in hospital in collaboration with hospital Medical Director.
  • Improved coordination of nursing and psychiatry staff activities to improve staff morale and patient care quality.
University Of Florida - Staff Psychiatrist
Gainesville, FL, 04/2004 - 01/2019
  • Designed individualized care plans and conducted lab or diagnostic tests on patients to provide further information regarding particular mental disorders and general physical conditions.
  • Collaborated with nurses, doctors, social workers and psychologist to discuss treatment plans and progress.
  • Assessed patients by reviewing mental and physical health along with individual backgrounds and current social situations.
  • Worked directly with patients suffering from range of mental health problems and provided good standard of practice care.
  • Carried out research in clinical trials as Principal Investigator, site Principal Investigator, and Co-Investigator and kept up-to-date with new information relevant to field.
  • Prescribed and administered psychotherapeutic treatments or medications to treat mental, addictive and behavioral disorders.
Dana-Farber Cancer Institute - Medical Director, Adolescent AODA IOP
Boston, MA, 10/2004 - 05/2008
  • Developed and actualized strategies to maintain highest standards of care provided by Master's Level staff for adolescents with substance abuse problems and their families.
  • Maintained certification of the adolescent substance abuse Intensive Outpatient Program with state and JCAHO reviews.
Dean Foundation For Medical Research - Clinical Trials Investigator
City, STATE, 04/2001 - 09/2004
  • Oversaw teams of investigators completing successful outpatient clinical trials of several medications for the treatment of substance use and other mental disorders.
  • In some studies, served as co-investigator with a principal investigator.
  • Audited and oversaw high quality of study records and supporting documentation.
  • Conducted and oversaw eligibility screening and physical, psychiatric, laboratory and other diagnostic testing to assure safety and eligibility of study subjects.
  • Conducted and oversaw ongoing study care for subjects, including study medication assessment and dispensation, clinical response, and assurance of good clinical care and practices.
  • Evaluated and, where reportable, reported adverse events experienced by study subjects, including all serious adverse events, after thorough data collection and careful consultation with other physicians, study monitors, and medical director of clinical trial of sponsoring pharmaceutical companies.
Gateway Recovery Center - Medical Director
City, STATE, 09/1999 - 04/2004
  • Supervised Master's level therapists providing substance abuse and mental health treatment services for HMO patients in this University Hospital affiliated clinic.
  • Oversaw documentation, treatment plans, and clinical outcomes measurements.
  • Developed new programs for the treatment of adolescent substance abusers, stimulant use disorders, and opioid use disorders, including a comprehensive medication/motivational interviewing program and a PTSD/substance use disorder program.
  • Developed policies and procedures that guided all clinical programming.
  • Guided and provided oversight for quality improvement programming that led to the program's recognition as the best in Wisconsin and repeatedly achieved recertification by state authorities and attracted visitors from around the U.S.
  • Quadrupled capitation-based funding contracts with 3 regional HMOs .
  • Reduced staff turnover by 80%.
Beloit Memorial Hospital - Staff Psychiatrist
City, STATE, 09/1997 - 09/1999
  • Collaborated with nurses, doctors, social workers and psychologist to discuss treatment plans and progress.
  • Designed individualized care plans and conducted lab or diagnostic tests on patients to provide further information regarding particular mental disorders and general physical conditions.
  • Assessed patients by reviewing mental and physical health along with individual backgrounds and current social situations.
  • Worked directly with patients suffering from range of mental health problems and provided good standard of practice care.
University Of Wisconsin School Of Medicine And Public Health - Assistant Professor
City, STATE, 07/1992 - 07/1997
  • Evaluated and supervised student activities and performance levels to provide reports on academic progress in basic psychiatric sciences and clinical care of psychiatric patients.
  • Supervised and trained psychiatric residents..
  • Developed custom course syllabus outlining standards, material, grading and progression for students.
  • Provided outpatient and inpatient consultative care for patients with substance use and other psychiatric disorders.
  • Served as Principal Investigator, site Principal Investigator, and co-investigator in clinical trials sponsored by NIH/NIAAA and several pharmaceutical companies, developing study protocols, recruiting potential subjects, evaluating study subject eligibility per protocol criteria, treating subjects per study protocol, and closing out the study, as well as assuring superior documentation, and completion of timely and comprehensive study reports,
University Of Wisconsin Hospital And Clinics - Resident Researcher
City, STATE, 07/1988 - 05/1990
  • Conducted clinical trials research on treatment of patients with anxiety disorders.
  • Conducted patient interviews to gather health history, vital signs and information about current medical issues.
  • Evaluated clinical status of patients in those controlled clinical trials.
University Of Wisconsin Hospital And Clinics - Research Fellow
City, STATE, 07/1985 - 06/1986
  • Coordinated eligibility assessments, worked with clinical pharmacy to deliver randomized IV antibiotic doses for administration in immediate pre-operative period, and follow patients for evidence of adverse medication reactions and evidence of post-operative infections following cardiovascular surgery procedures in this single-site, controlled clinical trial of > 350 subjects.
Activities and Honors

AWARDS AND HONORS

1975 Knapp Foundation Scholarship for Undergraduate Honors Thesis

1975 Trewartha Scholarship for Undergraduate Honors research

1975 University of Wisconsin Bookstore Award for Academic Excellence

1977-1980 Departmental Honors for Academic Achievement, MIT Biology Department

1981-1985 Honor Roll, UW Medical School

1984 Alpha Omega Alpha Medical Honor Fraternity election, Junior Year, UW Medical School,

1984 Vincent Russo Award "for leadership and character among medical students," UW Medical School

1985 Evan and Marion Helfaer Scholarship "for outstanding academic achievement as a medical student"

1995 Exemplary Psychiatrist Award, Alliance for the Mentally Ill of Dane County, Inc.

1995 Exemplary Psychiatrist Award, National Alliance for the Mentally Ill

2001 Outstanding Professional Service Award, Wisconsin Alcohol and Other Drug Abuse

Association

2004-2014 Listed in “Top Psychiatrists in America” for Addiction Psychiatry by Consumers

Research Council of America

2009-2019 Named in Who’s Who in America

2013 Named by M Milwaukee Magazine as a Best Doctor in Milwaukee

2017 First place (among 32 projects) award (with Jessica McNett MD), Aurora Medical

Group Leadership Development Project

2017 LEAN Green Belt Certification (Gold Level) for Medical Leadership, 2017, Irish

Institute of Industrial Engineers

2019 Elected to National Society of Academic Excellence

2019-2022 Named a Top Psychiatrist on FindaTopDoc.com, and spotlighted in The Leading Physicians of the World.

PAST GRANT & RESEARCH SUPPORT (1990-2007)

1. Investigator in "Novel Pharmacotherapies for Alcoholism" Project of University of Connecticut

Alcohol Research Center, NIAAA Grant 2P50-AA 03510; Roger E. Meyer, M.D., Principal

Investigator; Henry R. Kranzler, M.D., and Thomas F. Babor, Ph.D., Project Investigators.

2. Investigator in "Diagnosis of Drug Abuse: Clinical Implications", NIDA Grand R01-DA The APT Foundation; Bruce Rounsaville, M.D., and Thomas F. Babor, Ph.D., Principal Investigators.

3. Postdoctoral Trainee in "University of Connecticut Postdoctoral Training in Alcohol Studies", NIAAA Grant 5T32-AA 07290; Victor M. Hesselbrock, Ph.D., Principal Investigator.

4. Project Investigator in "A Randomized Study of Two Doses of Naltrexone in Heavy Drinkers",

Pilot Project of University of Connecticut Alcohol Research Center, NIAAA Grant 2P50-AA

-03510; Roger E. Meyer, M.D., Principal Investigator.

5. Principal Investigator in "Dimensions of Alcohol Urges in Abstinent Alcoholics"; grant from University of Wisconsin Medical School; 1992-93.

6. Principal Investigator in "Reliability and Validity of Substance Abuse Screening Instruments in Chronically Mentally Ill"; grant from University of Wisconsin-Madison Graduate School; 1992-1994.

7. Site Principal Investigator in "RIT-USA-40/A-Ritanserin in the treatment of Alcohol Dependence: A double-blind, placebo-controlled phase III study" sponsored by Janssen Pharmaceuticals; 1994-1995

8. Site Principal Investigator in "Ritanserin in the Treatment of Alcohol Dependence: An open label extension study," sponsored by Janssen Pharmaceuticals; 1994-1995.

9. Principal Investigator in "An Open Label Usage Study of Trexan [naltrexone] as Adjunctive Treatment with Psychosocial Therapy for Individuals with Alcoholism"; sponsored by DuPont Pharma; 1994-1995.

10. Principal Investigator for Training, Integrated Dual Diagnosis CSP Model, contract with Mental

Health Center of Dane County, Inc. and Dane County Department of Human Services

11. Co-Investigator in "Temporal Relationship of Dieting, Stress, Binge-Eating, and Alcohol Use in

Young Women"; sponsored by Alcoholic Beverage Medical Research Foundation; 3/1/96-2/28/98; Dean D. Krahn, M.D., Principal Investigator.

12. Principal Investigator for "Naltrexone and Brief Counseling for Heavy Drinkers," sponsored by National Institute on Alcohol Abuse and Alcoholism [NIAAA]; R29AA09948, 5/94-4/98.

13. Co-Investigator in “Computerized Assessments to Predict Alcoholism Treatment Dropout,” NIAAA SBIR Award; James Mundt, Ph.D., Principal Investigator. 2000-2002

14. Investigator in “CPH-101 [Nalmefene] In Heavy Alcohol Drinkers With Impaired Control.

A 12 + 40-week placebo controlled dose response study.” Sponsored by Oy Contral Pharma Ltd. Leslie Taylor, M.D., Site Principal Investigator 2000-2001

15. Site Principal Investigator for “Protocol #: Naltrel 99-03: Safety and Efficacy of Naltrel in Treatment of Alcohol Dependence, ” sponsored by Drug Abuse Sciences 2001-2003

16. Investigator in “Protocol AK 130936: A 7 Month, Multicenter, Randomized, Double-blind, Placebo-Controlled Comparison of 150-300mg/day of Extended-release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Affective Disorder in Subjects with a History of Seasonal Affective Disorder followed by an 8 week Observational Follow-up Phase,” sponsored by Glaxo Smith Kline Pharmaceuticals; Leslie vH Taylor, M.D., site Principal Investigator 2002-2003

17. Investigator in “Protocol 0600B5-355-US: A Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study of Venlafaxine ER in Adolescent Outpatients with Panic,” sponsored by Wyeth Pharmaceuticals; Leslie vH Taylor, M.D., site Principal Investigator 2002-2003

18. Investigator in “Shire SPD503-303: A Phase III, Open-Label Study of SPD503 in Children and

Adolescents (aged 6-17) with Attention Deficit Hyperactivity Disorder,” sponsored by Shire Pharmaceuticals; Leslie vH Taylor, M.D., site Principal Investigator 2002-2003

19. Investigator in “Protocol C-2002-012: A Placebo-Controlled, Double-Blind, Randomized, Parallel Study of the Efficacy and Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation,” sponsored by Alza Pharmaceuticals; Rise Futterer, M.D., M.P.H., site Principal Investigator 2003-2004

20. Investigator in “Protocol C-2002-014: An Open Label Study of the Long-term Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation,” sponsored by Alza Pharmaceuticals; Rise Futterer, M.D.,

M.P.H., site Principal Investigator 2003-2004

21. Investigator in “B4Z-MC-LYBM: A Double-Blind Study of Treatment Optimization with Atomoxetine Hydrochloride in Adults with DSM-IV Attention-Deficit/Hyperactivity Disorder,” sponsored by Eli Lilly; Leslie vH Taylor, M.D., site Principal Investigator 2003-2004

22. Investigator in “Protocol No: EFC4796: Comparison of the efficacy and safety of 2 oral doses of rimonabant, 5 mg/day or 20 mg/day, versus placebo, as an aid to maintenance of smoking cessation – a multiple country, randomized, double-blind, 5 arm, placebo-controlled, parallel-group, fixed dose, 2-

year, multi-center, Phase III trial; 1-year treatment, 1-year follow-up,” sponsored by Sanofi Synthelabo; Rise Futterer, M.D., M.P.H., site Principal Investigator 2003-2004

23. Site Principal Investigator for “Protocol ALK21-003-EXT: A Multi-Center, Double Blind, Extension of Alkermes Study ALK21-003 to Evaluate the Long-Term Safety of Medisorb® Naltrexone,” sponsored by Alkermes, Inc. 2002-2004

24. Site Principal Investigator for “Protocol ALK21-003: A Phase III, Multi-Center, Randomized, Double Blind, Placebo Controlled Study of the Efficacy and Safety of Medisorb Naltrexone in Alcohol Dependent Adults,” sponsored by Alkermes, Inc. 2003-2004

25. Investigator for “Effect of Ingestion of Palatable Foods on Alcohol Cravings and Relapse.” Merit Review Grant sponsored by Department of Veterans Affairs. Dean Krahn, M.D., Principal Investigator 2001-2004

26. Site Principal Investigator for “Protocol ALK21-006: A Randomized, Open-Label, Long-Term, Multi-Center Study of the Safety of Medisorb® Naltrexone,” sponsored by Alkermes, Inc; Leslie vH Taylor, M.D., site Investigator 2003-2004

27. Investigator for “Protocol CN 138089: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Aripiprazole in the Maintenance of Abstinence from Alcohol in Subjects with Alcoholism,” sponsored by Bristol-Myers Squibb Pharmaceutical Research Institute; Lance Longo, M.D., site Principal Investigator, 2004-2005

28. Site Principal Investigator for “Protocol SP-N0406:A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study To Assess the Efficacy and Safety of Nalmefene HCl In The Treatment of Pathological Gambling,” sponsored by Somaxon Pharmaceuticals, Inc.

29. Co-Principal Investigator for “Investigator Initiated Study: Placebo-Controlled, Randomized, Double Blind Study of Acamprosate for Treatment of Alcohol Dependence in Primary Care,“ sponsored by Forest Pharmaceuticals; Lance P. Longo, M.D., Co-Principal Investigator.

30. Project Champion/Principal Investigator for “Reducing Youth Substance Abuse through Brief Motivational Interviewing in Schools”, awarded to Aurora Behavioral Health and sponsored by Wisconsin Partnership Fund

31. Project Manager and Investigator for "Randomized, Double-Blind, Controlled Study Comparing Vancomycin, Cefazolin and Cefamandole in the Prevention of Post-Operative Infections following Cardiovascular Surgery; Dennis K. Maki, M.D., Principal Investigator.

By clicking Customize This Resume, you agree to our Terms of Use and Privacy Policy

Your data is safe with us

Any information uploaded, such as a resume, or input by the user is owned solely by the user, not LiveCareer. For further information, please visit our Terms of Use.

Resume Overview

School Attended

  • University of Wisconsin Medical School
  • Massachusetts Institute of Technology
  • University of Wisconsin - Madison

Job Titles Held:

  • Physician-psychiatrist
  • Chief Medical Officer
  • Chief, Hospitalist Psychiatry Section
  • Medical Director, Intensive Psychiatric Treatment
  • Staff Psychiatrist
  • Medical Director, Adolescent AODA IOP
  • Clinical Trials Investigator
  • Medical Director
  • Staff Psychiatrist
  • Assistant Professor
  • Resident Researcher
  • Research Fellow

Degrees

  • M.D.
  • ABD For PhD
  • Bachelor of Science

By clicking Customize This Resume, you agree to our Terms of Use and Privacy Policy

*As seen in:As seen in: